Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
Angiolillo, Dominick J
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. [electronic resource] - Circulation 07 2018 - 527-536 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1524-4539
10.1161/CIRCULATIONAHA.118.034722 doi
Administration, Oral
Anticoagulants--administration & dosage
Atrial Fibrillation--blood
Blood Coagulation--drug effects
Clinical Decision-Making
Consensus
Coronary Artery Disease--blood
Coronary Thrombosis--blood
Drug Therapy, Combination
Evidence-Based Medicine
Fibrinolytic Agents--administration & dosage
Hemorrhage--chemically induced
Humans
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--administration & dosage
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. [electronic resource] - Circulation 07 2018 - 527-536 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1524-4539
10.1161/CIRCULATIONAHA.118.034722 doi
Administration, Oral
Anticoagulants--administration & dosage
Atrial Fibrillation--blood
Blood Coagulation--drug effects
Clinical Decision-Making
Consensus
Coronary Artery Disease--blood
Coronary Thrombosis--blood
Drug Therapy, Combination
Evidence-Based Medicine
Fibrinolytic Agents--administration & dosage
Hemorrhage--chemically induced
Humans
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--administration & dosage
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome